Continuity Biosciences LLC

Continuity Biosciences LLC

This company develops implantable drug delivery platforms and cell reprogramming technologies for biopharmaceutical partners to treat chronic diseases and solid tumours.

Intarcia Therapeutics

This biopharmaceutical company develops subcutaneous drug delivery implants for patients with chronic diseases such as type 2 diabetes and HIV.

Surf Bio

This company develops drug stabilisation and delivery platforms for pharmaceutical manufacturers to enable high-concentration subcutaneous administration of biologics and vaccines.

NanoPhoria

This company develops an inhalable nano-drug delivery platform and therapeutics for patients with heart failure and other cardiovascular diseases.

Beta Bionics

This company develops an autonomous insulin delivery system for children and adults living with type 1 diabetes to manage their glucose levels.

Nanodyne

Nanodyne develops non-invasive microfluidic skin sensors for continuous monitoring of blood glucose and other biometrics for healthcare providers and patients.

G2GBIO

This company develops long-acting injectable medicines and drug delivery platforms for pharmaceutical companies and patients with chronic diseases.

Elektrofi

The company develops a microparticle technology platform that enables subcutaneous self-administration of high-concentration biologic medicines for biopharmaceutical firms and their patients.